21 found
Order:
See also
Peter H. Schwartz
Indiana University Purdue University, Indianapolis
  1. Defining Dysfunction: Natural Selection, Design, and Drawing a Line.Peter H. Schwartz - 2007 - Philosophy of Science 74 (3):364-385.
    Accounts of the concepts of function and dysfunction have not adequately explained what factors determine the line between low‐normal function and dysfunction. I call the challenge of doing so the line‐drawing problem. Previous approaches emphasize facts involving the action of natural selection (Wakefield 1992a, 1999a, 1999b) or the statistical distribution of levels of functioning in the current population (Boorse 1977, 1997). I point out limitations of these two approaches and present a solution to the line‐drawing problem that builds on the (...)
    Download  
     
    Export citation  
     
    Bookmark   49 citations  
  2. Reframing the Disease Debate and Defending the Biostatistical Theory.Peter H. Schwartz - 2014 - Journal of Medicine and Philosophy 39 (6):572-589.
    Similarly to other accounts of disease, Christopher Boorse’s Biostatistical Theory (BST) is generally presented and considered as conceptual analysis, that is, as making claims about the meaning of currently used concepts. But conceptual analysis has been convincingly critiqued as relying on problematic assumptions about the existence, meaning, and use of concepts. Because of these problems, accounts of disease and health should be evaluated not as claims about current meaning, I argue, but instead as proposals about how to define and use (...)
    Download  
     
    Export citation  
     
    Bookmark   11 citations  
  3. How Bioethics Principles Can Aid Design of Electronic Health Records to Accommodate Patient Granular Control.Eric M. Meslin & Peter H. Schwartz - 2014 - Journal of General Internal Medicine 30 (1):3-6.
    Ethics should guide the design of electronic health records (EHR), and recognized principles of bioethics can play an important role. This approach was adopted recently by a team of informaticists designing and testing a system where patients exert granular control over who views their personal health information. While this method of building ethics in from the start of the design process has significant benefits, questions remain about how useful the application of bioethics principles can be in this process, especially when (...)
    Download  
     
    Export citation  
     
    Bookmark  
  4. Decision and Discovery in Defining “Disease”.Peter H. Schwartz - 2007 - In Harold Kincaid & Jennifer McKitrick (eds.), Establishing medical reality: Methodological and metaphysical issues in philosophy of medicine. Dordrecht: Springer. pp. 47-63.
    Download  
     
    Export citation  
     
    Bookmark   15 citations  
  5. Risk and Disease.Peter H. Schwartz - 2008 - Perspectives in Biology and Medicine 51 (3):320-334.
    The way that diseases such as high blood pressure (hypertension), high cholesterol, and diabetes are defined is closely tied to ideas about modifiable risk. In particular, the threshold for diagnosing each of these conditions is set at the level where future risk of disease can be reduced by lowering the relevant parameter (of blood pressure, low-density lipoprotein, or blood glucose, respectively). In this article, I make the case that these criteria, and those for diagnosing and treating other “risk-based diseases,” reflect (...)
    Download  
     
    Export citation  
     
    Bookmark   15 citations  
  6. Questioning the Quantitative Imperative: Decision Aids, Prevention, and the Ethics of Disclosure.Peter H. Schwartz - 2011 - Hastings Center Report 41 (2):30-39.
    Patients should not always receive hard data about the risks and benefits of a medical intervention. That information should always be available to patients who expressly ask for it, but it should be part of standard disclosure only sometimes, and only for some patients. And even then, we need to think about how to offer it.
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  7. Giving Patients Granular Control of Personal Health Information: Using an Ethics ‘Points to Consider’ to Inform Informatics System Designers.Eric M. Meslin, Sheri A. Alpert, Aaron E. Carroll, Jere D. Odell, William M. Tierney & Peter H. Schwartz - 2013 - International Journal of Medical Informatics 82:1136-1143.
    Objective: There are benefits and risks of giving patients more granular control of their personal health information in electronic health record (EHR) systems. When designing EHR systems and policies, informaticists and system developers must balance these benefits and risks. Ethical considerations should be an explicit part of this balancing. Our objective was to develop a structured ethics framework to accomplish this. -/- Methods: We reviewed existing literature on the ethical and policy issues, developed an ethics framework called a “Points to (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  8. The Ethics of Information: Absolute Risk Reduction and Patient Understanding of Screening.Peter H. Schwartz & Eric M. Meslin - 2008 - Journal of General Internal Medicine 23 (6):867-870.
    Some experts have argued that patients should routinely be told the specific magnitude and absolute probability of potential risks and benefits of screening tests. This position is motivated by the idea that framing risk information in ways that are less precise violates the ethical principle of respect for autonomy and its application in informed consent or shared decisionmaking. In this Perspective, we consider a number of problems with this view that have not been adequately addressed. The most important challenges stem (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  9. Small Tumors as Risk Factors Not Disease.Peter H. Schwartz - 2014 - Philosophy of Science 81 (5):986-998.
    I argue that ductal carcinoma in situ (DCIS), the tumor most commonly diagnosed by breast mammography, cannot be confidently classified as cancer, that is, as pathological. This is because there may not be dysfunction present in DCIS—as I argue based on its high prevalence and the small amount of risk it conveys—and thus DCIS may not count as a disease by dysfunction-requiring approaches, such as Boorse’s biostatistical theory and Wakefield’s harmful dysfunction account. Patients should decide about treatment for DCIS based (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  10. Proper Function and Recent Selection.Peter H. Schwartz - 1999 - Philosophy of Science 66 (3):210-222.
    "Modern History" versions of the etiological theory claim that in order for a trait X to have the proper function F, individuals with X must have been recently favored by natural selection for doing F (Godfrey-Smith 1994; Griffiths 1992, 1993). For many traits with prototypical proper functions, however, such recent selection may not have occurred: traits may have been maintained due to lack of variation or due to selection for other effects. I examine this flaw in Modern History accounts and (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  11. Autonomy and Consent in Biobanks.Peter H. Schwartz - 2010 - The Physiologist 53 (1):1, 3-7.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  88
    Patient Understanding of Benefits, Risks, and Alternatives to Screening Colonoscopy.Peter H. Schwartz, Elizabeth Edenberg, Patrick R. Barrett, Susan M. Perkins, Eric M. Meslin & Thomas F. Imperiale - 2013 - Family Medicine 45 (2):83-89.
    While several tests and strategies are recommended for colorectal cancer (CRC) screening, studies suggest that primary care providers often recommend colonoscopy without providing information about its risks or alternatives. These observations raise concerns about the quality of informed consent for screening colonoscopy.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  13. Discounting a Surgical Risk: Data, Understanding, and Gist.Peter H. Schwartz - 2012 - American Medical Association Journal of Ethics 14 (7):532-538.
    Download  
     
    Export citation  
     
    Bookmark  
  14. To Be or Not to Be – A Research Subject.Eric M. Meslin & Peter H. Schwartz - 2010 - In Thomasine Kushner (ed.), Surviving Health Care: A Manual for Patients and their Families. Cambridge: Cambridge University Press. pp. 146-162.
    Most people do not know there are different kinds of medical studies; some are conducted on people who already have a disease or medical condition, and others are performed on healthy volunteers who want to help science find answers. No matter what sort of research you are invited to participate in, or whether you are a patient when you are asked, it’s entirely up to you whether or not to do it. This decision is important and may have many implications (...)
    Download  
     
    Export citation  
     
    Bookmark  
  15. Older Adults and Forgoing Cancer Screening.Alexia M. Torke, Peter H. Schwartz, Laura R. Holtz, Kianna Montz & Greg A. Sachs - 2013 - Journal of the American Medical Association Internal Medicine 173 (7):526-531.
    Although there is a growing recognition that older adults and those with extensive comorbid conditions undergo cancer screening too frequently, there is little information about patients’ perceptions regarding cessation of cancer screening. Information on older adults’ views of screening cessation would be helpful both for clinicians and for those designing interventions to reduce overscreening.
    Download  
     
    Export citation  
     
    Bookmark  
  16. Disclosure and Rationality: Comparative Risk Information and Decision-Making About Prevention.Peter H. Schwartz - 2009 - Theoretical Medicine and Bioethics 30 (3):199-213.
    With the growing focus on prevention in medicine, studies of how to describe risk have become increasing important. Recently, some researchers have argued against giving patients “comparative risk information,” such as data about whether their baseline risk of developing a particular disease is above or below average. The concern is that giving patients this information will interfere with their consideration of more relevant data, such as the specific chance of getting the disease (the “personal risk”), the risk reduction the treatment (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  17.  74
    The Value of Information and the Ethics of Personal-Genomic Screening.Peter H. Schwartz - 2009 - American Journal of Bioethics 9 (4):26-27.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  18. Comparative Risk: Good or Bad Heuristic?Peter H. Schwartz - 2016 - American Journal of Bioethics 16 (5):20-22.
    Some experts have argued that patients facing certain types of choices should not be told whether their risk is above or below average, because this information may trigger a bias (Fagerlin et al. 2007). But careful consideration shows that the comparative risk heuristic can usefully guide decisions and improve their quality or rationality. Building on an earlier paper of mine (Schwartz 2009), I will argue here that doctors and decision aids should provide comparative risk information to patients, even while further (...)
    Download  
     
    Export citation  
     
    Bookmark  
  19.  97
    Placebos, Full Disclosure, and Trust: The Risks and Benefits of Disclosing Risks and Benefits.Peter H. Schwartz - 2015 - American Journal of Bioethics 15 (10):13-14.
    Download  
     
    Export citation  
     
    Bookmark  
  20. Child Safety, Absolute Risk, and the Prevention Paradox.Peter H. Schwartz - 2012 - Hastings Center Report 42 (4):20-23.
    Imagine you fly home from vacation with your one-and-a-half-year-old son who is traveling for free as a “lap child.” In the airport parking lot, you put him into his forward-facing car seat, where he sits much more contentedly than he did in the rear-facing one that was mandatory until his first birthday. After he falls asleep on the way home, you transfer him to his crib without waking him, lowering the side rail so you can lift him in more easily. (...)
    Download  
     
    Export citation  
     
    Bookmark  
  21.  73
    Silence About Screening.Peter H. Schwartz - 2007 - American Journal of Bioethics 7 (7):46-48.
    Download  
     
    Export citation  
     
    Bookmark   1 citation